Ketanest ( DrugBank: - )

3 diseases

2. 筋萎縮性側索硬化症

臨床試験数 : 624 / 薬物数 : 611 - (DrugBank : 160) / 標的遺伝子数 : 172 - 標的パスウェイ数 : 225

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-000142-18-FI (EUCTR)	09/05/2018	08/05/2018	Feasibility and effects of subcutaneously given combination of dexmedetomidine and ketamine in ALS p ...	Feasibility and pharmacodynamics of subcutaneously given combination of dexmedetomidine and ketamine ...	Amyotrophic lateral sclerosis (ALS) MedDRA version: 20.1;Level: LLT;Classification code 10036704;Ter ...	Trade Name: Dexdor INN or Proposed INN: DEXMEDETOMIDINE Trade Name: Ketanest-S INN or Proposed INN: ESK ...	Turku University Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	20	Phase 4	Finland

臨床試験数 : 7 / 薬物数 : 17 - (DrugBank : 9) / 標的遺伝子数 : 19 - 標的パスウェイ数 : 32

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-000142-18-FI (EUCTR)	09/05/2018	08/05/2018	Feasibility and effects of subcutaneously given combination of dexmedetomidine and ketamine in ALS p ...	Feasibility and pharmacodynamics of subcutaneously given combination of dexmedetomidine and ketamine ...	Amyotrophic lateral sclerosis (ALS) MedDRA version: 20.1;Level: LLT;Classification code 10036704;Ter ...	Trade Name: Dexdor INN or Proposed INN: DEXMEDETOMIDINE Trade Name: Ketanest-S INN or Proposed INN: ESK ...	Turku University Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	20	Phase 4	Finland

臨床試験数 : 96 / 薬物数 : 203 - (DrugBank : 60) / 標的遺伝子数 : 66 - 標的パスウェイ数 : 89

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2016-002887-14-FI (EUCTR)	31/10/2016	14/10/2016	Dose-response of ketamine in patient controlled analgesia in orthopaedic surgery patients	Dose response study of Patient Controlled Analgesia (PCA) of S-ketamine in orthopaedic spine surgery ...	Patients who are scheduled for elective posterolateral lumbar spine fusion with bilateral transpedic ...	Trade Name: Ketanest-S INN or Proposed INN: KETAMINE Trade Name: Oxycodone Orion INN or Proposed INN: O ...	University of Turku	NULL	Not Recruiting			Female: yes Male: yes	100	Phase 1;Phase 4	Finland
2	EUCTR2012-000747-26-FI (EUCTR)	27/04/2012	02/04/2012	Ketamine to reduce postoperative pain in back surgery	Administration of S-Ketamine during spinal surgery to reduce postoperative pain	adult patients undergoing spinal surgery MedDRA version: 14.1;Level: LLT;Classification code 1004159 ...	Trade Name: Ketanest-S Product Name: Ketanest-S Other descriptive name: ESKETAMINE HYDROCHLORIDE	Helsinki Universiy Central Hospital	NULL	Not Recruiting			Female: yes Male: yes	192	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	Finland